In the genes - Gene-cell therapies
Duchenne Muscular Dystrophy can devastate a person’s life, resulting in mobility limitation and heart failure. Now, the latest in gene technology is being used to offer targeted therapies to patients in order to bring expertise to this vital area.
Currently, the only licensed therapy for ischaemic stroke remains largely unsuitable for many due to patients being naturally resistant to the treatment. As a result, there remains an urgent need for an accurate alternative for this vital treatment.
Chemistry and PhysicsPharmaPhysical Sciences
Picking the winners - Manchester BioFactory Ltd
Manchester BioFactory will transform the speed and efficiency at which biology can be engineered, delivering high performance products to the biotechnology industry. Our vision is to transform bioindustry to create an efficient, green, and sustainable future. Do more, use less.
VR-Evo - Digital Doctors
With cutting-edge technology as sharp as a scalpel, VREvo Ltd has the means to train a new generation of healthcare professionals with virtual reality, using simulated surgeons, pretend patients, and all manner of virtual organs to get results.
Health and Biotech
A vision of success - Complement Therapeutics Ltd
Taking on two devastating immune system diseases, AMD and GA, Complement Therapeutics Ltd is developing new strategies to enhance one of the most promising areas in patient care.